Our Story

Our Story and Commitment to Excellence

Founded in 2022, 3D Lifesciences quickly established itself in the life science industries as a reliable and consistent source of high quality supportive care products. Subsequent acquisitions of strategic industry providers coupled with targeted expansion have extended our reach to healthcare professionals across India, allowing 3D Lifesciences to continue to anticipate and meet the needs of the customers we serve.

Our Commitment

Our commitment to delivering exceptional value through patient-centred innovation and continuous improvement across all areas of our business is unwavering.

Our People

Our dedicated team of experts is comprised of passionate experts who love working hard and collaborate effortlessly across borders to accomplish a shared mission.

Our Foundation

Core Principles

shield_with_heart

Patient-Centred

A commitment to delivering exceptional value through patient-centred innovation across all areas of our business.

verified

Quality & Consistency

A reliable and consistent source of high quality supportive care products since our founding.

trending_up

Continuous Improvement

Continuous improvement and targeted expansion to anticipate and meet the needs of our customers.

What We Do

Supportive Care, Delivered with Care

3D Life Sciences is a pharmaceutical company serving healthcare professionals across India, dedicated to supportive care — medicines and formulations designed to stand alongside primary treatment and ease the everyday burden of serious illness. Our work spans Oncology, Urology, Gastroenterology and Nephrology, where we focus on the practical, day-to-day needs of patients undergoing treatment rather than the treatment of disease itself.

Every formulation we bring to market is developed with a scientific and quality-driven approach, from ingredient sourcing through to manufacturing, so that healthcare professionals can rely on consistency batch after batch. We see ourselves as a long-term partner to the clinicians who prescribe our products and the patients who depend on them — our goal is simple: to improve quality of life through specialised, dependable supportive care.

What We Do

Supportive Care Across Critical Specialties

3D Life Sciences develops supportive care medicines — formulations designed to be used alongside primary treatment, easing the everyday burden that comes with managing a serious condition. Our portfolio is built around the practical needs of patients during treatment, not the treatment of disease itself.

Each formulation is developed with a scientific and quality-driven approach, and every batch is held to the same standard so that the healthcare professionals who prescribe our products can rely on what they recommend. We work closely with clinicians across our focus areas to make sure our medicines fit into real treatment pathways.

Today that work spans Oncology, Urology, Gastroenterology and Nephrology. We see this as the beginning of a longer commitment: building a dependable supportive care portfolio that genuinely improves quality of life, specialty by specialty.

OncologyUrologyGastroenterologyNephrology

Advancing cancer treatment with supportive care medicines.Innovative solutions for improved urinary health.Enhancing digestive health with advanced treatments.Specialized therapies supporting kidney health and renal care.

Leadership Perspectives

A Word From Leadership

Purnendu Maity

Founder & Managing Director

Shrabanti Maity

Director

Koyal Bhattacharya

Director

When we founded 3D Life Sciences in 2022, we made one commitment to ourselves: every medicine that carries our name would be built on scientific integrity, not shortcuts. That commitment has not changed, and it never will.

Supportive care exists in the space between diagnosis and recovery — the part of a patient’s journey that is rarely spoken about, but felt every single day. Our work across Oncology, Urology, Gastroenterology and Nephrology is built around that reality. We are not trying to treat disease; we are trying to make the experience of treatment more bearable, more dignified, for the people living through it.

Trust is earned one batch at a time. It is why we hold every formulation to the same quality standard regardless of scale, and why we work as closely with the clinicians who prescribe our medicines as we do with the scientists who develop them. A healthcare professional should never have to think twice about what they are recommending.

We are still early in our journey, and we intend to stay restless about it — continuously improving what we already make, and deliberately expanding into IVF, Neurology, Cardiac Care and Diabetic Care in the years ahead. But our focus will always come back to the same question: does this genuinely improve a patient’s quality of life. If the answer is yes, we build it. If not, we don’t.

My focus at 3D Life Sciences has always been on the people behind every prescription — the patients managing a difficult diagnosis, and the clinicians trying to make their treatment more tolerable. Supportive care only works if it is dependable, and dependability is something we take personally.

We have built our team around scientific rigor and a genuine respect for the responsibility that comes with manufacturing medicine. Every expansion we consider, every new formulation we explore, is measured against the same standard: does it meet a real, unmet need for the patients we serve across Oncology, Urology, Gastroenterology and Nephrology.

Quality is not a department at 3D Life Sciences — it is a discipline that runs through the entire organisation, and I am proud of how seriously our people carry that responsibility.

I came into this industry believing that a pharmaceutical company's real product is trust, and everything we do at 3D Life Sciences is in service of that belief. From sourcing to manufacturing to the way we support the clinicians who recommend our medicines, consistency is non-negotiable.

Our therapeutic focus areas — Oncology, Urology, Gastroenterology and Nephrology — were not chosen at random. They represent some of the most demanding day-to-day realities patients face during treatment, and that is exactly where supportive care needs to show up reliably, batch after batch.

We see continuous improvement as a permanent project, not a milestone. As we grow, our priority will always be to expand thoughtfully, never at the expense of the standards our patients and partners have come to expect from us.

Purnendu MaityShrabanti MaityKoyal Bhattacharya

Founder & Managing DirectorDirectorDirector

Our Journey

From Founding to the Future

2022

Founded in Kolkata

Founded in 2022, 3D Lifesciences quickly established itself in the life science industries as a reliable and consistent source of high quality supportive care products.

Growth

Acquisitions & Expansion

Subsequent acquisitions of strategic industry providers, coupled with targeted expansion, broadened our supportive care portfolio and extended our reach to healthcare professionals across India.

Today

Oncology · Urology · Gastroenterology · Nephrology

Focused on critical therapeutic areas, delivering supportive care medicines that enhance quality of life.

Future

Expanding Our Reach

Aiming to establish ourselves in IVF, Neurology, Cardiac Care, Diabetic Care in the near future.

Curious about our work beyond the page? Explore Our Events

Get in touch

Partner with us in supportive care

For product information, distribution or collaboration, our team would be glad to hear from you.

View Our Products Contact Us